Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
Crossref DOI link: https://doi.org/10.1186/s12943-015-0477-z
Published Online: 2015-12-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kreuz, S.
Holmes, K. B.
Tooze, R. M.
Lefevre, P. F. https://orcid.org/0000-0002-3951-3546
Funding for this research was provided by:
Yorkshire Cancer Research (GB) (LOO2 PH)
